155 related articles for article (PubMed ID: 12435532)
1. Management of toe onychomycosis: what is the potential for improving efficacy of treatment?
Gupta AK
Clin Dermatol; 2002; 20(5):607-9. PubMed ID: 12435532
[No Abstract] [Full Text] [Related]
2. A financial perspective on the topical treatment of onychomycosis.
Lagrew JP
J Am Acad Dermatol; 2016 Jul; 75(1):e37. PubMed ID: 27317544
[No Abstract] [Full Text] [Related]
3. [Onychomycosis].
Sato T
Med Mycol J; 2016; 57(4):J171-J173. PubMed ID: 27904063
[No Abstract] [Full Text] [Related]
4. Efficacy of fluconazole at a 400 mg weekly dose for the treatment of onychomycosis.
Hryncewicz-Gwóźdź A; Plomer-Niezgoda E; Kalinowska K; Czarnecka A; Maj J; Jagielski T
Acta Derm Venereol; 2015 Feb; 95(2):251-2. PubMed ID: 24942666
[No Abstract] [Full Text] [Related]
5. Response to "A financial perspective on the topical treatment of onychomycosis".
Elewski BE
J Am Acad Dermatol; 2016 Jul; 75(1):e39. PubMed ID: 27317545
[No Abstract] [Full Text] [Related]
6. Today's treatments options for onychomycosis.
Iorizzo M; Piraccini BM; Tosti A
J Dtsch Dermatol Ges; 2010 Nov; 8(11):875-9. PubMed ID: 20738460
[TBL] [Abstract][Full Text] [Related]
7. Tavaborole topical solution (Kerydin) for onychomycosis.
Med Lett Drugs Ther; 2015 Mar; 57(1463):35-6. PubMed ID: 25719999
[No Abstract] [Full Text] [Related]
8. The new oral antifungal agents for onychomycosis of the toenails.
Gupta AK; Shear NH
J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
[TBL] [Abstract][Full Text] [Related]
9. White superficial onychomycosis of a toenail due to Microsporum canis.
Lee HJ; Ha SJ; Lee SJ; Kim JW; Cho BK
Acta Derm Venereol; 2000; 80(2):155. PubMed ID: 10877147
[No Abstract] [Full Text] [Related]
10. Update on current approaches to diagnosis and treatment of onychomycosis.
Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V
Expert Rev Anti Infect Ther; 2018 Dec; 16(12):929-938. PubMed ID: 30411650
[TBL] [Abstract][Full Text] [Related]
11. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
Elewski BE; Cantrell W; Lin T
J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
[TBL] [Abstract][Full Text] [Related]
12. Case of infantile onychomycosis successfully cured by 5% amorolfine nail lacquer.
Chen S; Ran YP; Dai YL; Lama J; Hu WY
J Paediatr Child Health; 2014 Nov; 50(11):933-4. PubMed ID: 25376356
[No Abstract] [Full Text] [Related]
13. [Onychomycosis : a crown jewel of dermatology].
Tietz HJ; Nenoff P
Hautarzt; 2012 Nov; 63(11):842-7. PubMed ID: 23064669
[TBL] [Abstract][Full Text] [Related]
14. Efinaconazole and Tavaborole.
Poulakos M; Grace Y; Machin JD; Dorval E
J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
[TBL] [Abstract][Full Text] [Related]
15. Placebo cure rates in the treatment of onychomycosis.
Gupta AK; Paquet M
J Am Podiatr Med Assoc; 2014 May; 104(3):277-82. PubMed ID: 24901587
[TBL] [Abstract][Full Text] [Related]
16. Introduction.
Stein Gold LF; Rosen T
Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S47. PubMed ID: 27096143
[No Abstract] [Full Text] [Related]
17. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
Iozumi K; Abe M; Ito Y; Uesugi T; Onoduka T; Kato I; Kato F; Kodama K; Takahashi H; Takeda O; Tomizawa K; Nomiyama T; Fujii M; Mayama J; Muramoto F; Yasuda H; Yamanaka K; Sato T; Oh-I T; Kasai H; Tsuboi R; Hattori N; Maruyama R; Omi T; Shimoyama H; Sei Y; Nakasu I; Nishimoto S; Hata Y; Mochizuki T; Fukuzawa M; Seishima M; Sugiura K; Katayama I; Yamamoto O; Shindo M; Kiryu H; Kusuhara M; Takenaka M; Watanabe S
J Dermatol; 2019 Aug; 46(8):641-651. PubMed ID: 31206779
[TBL] [Abstract][Full Text] [Related]
18. A practical application of onychomycosis cure - combining patient, physician and regulatory body perspectives.
Gupta AK; Versteeg SG; Shear NH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):281-287. PubMed ID: 30005134
[TBL] [Abstract][Full Text] [Related]
19. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
Gerasimchuk EV; Gerasimov VV; Molchanov BA
Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
[No Abstract] [Full Text] [Related]
20. British Association of Dermatologists' guidelines for the management of onychomycosis 2014.
Ameen M; Lear JT; Madan V; Mohd Mustapa MF; Richardson M
Br J Dermatol; 2014 Nov; 171(5):937-58. PubMed ID: 25409999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
